This led us to examine whether the enhanced mobilization of E-cadherin and weakening of junction strength observed in invasive mutant p53 pancreatic tumors (Figures 3 and 5) could also be partly reverted in these more aggressive metastatic lines from the E-cadherin-GFP mouse. Here, TP53 is linked to pancreatic neoplasm.